Results 101 to 110 of about 1,821 (152)
Some of the next articles are maybe not open access.
USE OF THE NEWER URICOSURIC AGENTS IN THE MANAGEMENT OF GOUT
JAMA, 1960Zoxazolamine in doses up to 125 mg., administered to patients with gout, increased the urinary excretion of uric acid and lowered the serum urate level. In some patients increasing the dosage to 250 mg. intensified these effects to the point of causing a urate crystalluria.
J E, SEEGMILLER, A I, GRAYZEL
openaire +2 more sources
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent.
Archives of internal medicine, 1978Interest in new diuretics with less side effects has led to the synthesis of ticrynafen, an uricosuric diuretic. This agent was compared with hydrochlorothiazide in a crossover design study involving 12 hypertensive men. Both agents significantly decreased mean arterial pressure from 8% to 18% in eight of the 12 patients.
J G, de Carvalho +3 more
openaire +1 more source
The Activity of AA-193, A New Uricosuric Agent, in Animals
1989A new uricosuric agent, 5-chloro-7,8-dihydro-3-phenylfuro[2,3-g]-1,2-benzisoxazole-7-carbo xylic acid (AA-193), was compared with other uricosurics in the rat, mouse and cebus monkey. In rats, probenecid and tienilic acid increased the urate excretion, but benzbromarone did not have the uricosuric activity.
T, Dan +5 more
openaire +2 more sources
Zoxazolamine as a Uricosuric Agent
Acta Medica Scandinavica, 1961Börje Kuhlbäck, Ahti Harjanne
openaire +1 more source
Molecular imaging in oncology: Current impact and future directions
Ca-A Cancer Journal for Clinicians, 2022Steven P Rowe, Martin G Pomper
exaly
RENAL EFFECTS OF URICOSURIC AGENTS IN THE CHIMPANZEE
The Journal of Pharmacology and Experimental Therapeutics, 1971G M, Fanelli, D L, Bohn, S S, Reilly
openaire +2 more sources
The Journal of Pharmacology and Experimental Therapeutics, 1972
G M, Fanelli +3 more
openaire +2 more sources
G M, Fanelli +3 more
openaire +2 more sources